S. Mattox

1.4k total citations
7 papers, 742 citations indexed

About

S. Mattox is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, S. Mattox has authored 7 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in S. Mattox's work include Multiple Myeloma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (3 papers). S. Mattox is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Cancer Treatment and Pharmacology (4 papers) and Cancer therapeutics and mechanisms (3 papers). S. Mattox collaborates with scholars based in United States. S. Mattox's co-authors include Sundar Jagannath, Bart Barlogie, Guido Tricot, D Bracy, S. Naucke, K.R. Desikan, Nikhil C. Munshi, David S. Siegel, Seema Singhal and Athanasios Fassas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bone.

In The Last Decade

S. Mattox

7 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Mattox United States	6	672	423	300	123	56	7	742
PR Greipp United States	11	577 0.9×	414 1.0×	289 1.0×	114 0.9×	38 0.7×	12	635
RA Kyle United States	9	436 0.6×	309 0.7×	207 0.7×	84 0.7×	45 0.8×	9	503
Luis Palomera Spain	10	596 0.9×	465 1.1×	345 1.1×	115 0.9×	50 0.9×	25	671
J Ackermann Austria	12	287 0.4×	280 0.7×	185 0.6×	87 0.7×	50 0.9×	17	445
Norbert Pescosta Italy	11	455 0.7×	420 1.0×	276 0.9×	62 0.5×	55 1.0×	23	614
Jose Estevam United States	11	627 0.9×	566 1.3×	361 1.2×	82 0.7×	45 0.8×	16	754
Friederike Schneider Germany	10	388 0.6×	331 0.8×	145 0.5×	175 1.4×	44 0.8×	16	662
D Borrego Spain	7	342 0.5×	186 0.4×	155 0.5×	105 0.9×	60 1.1×	11	414
M Teramura Japan	9	288 0.4×	167 0.4×	116 0.4×	136 1.1×	163 2.9×	11	516
TE Witzig United States	8	334 0.5×	261 0.6×	212 0.7×	105 0.9×	58 1.0×	8	451

Countries citing papers authored by S. Mattox

Since Specialization

Citations

This map shows the geographic impact of S. Mattox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Mattox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Mattox more than expected).

Fields of papers citing papers by S. Mattox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Mattox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Mattox. The network helps show where S. Mattox may publish in the future.

Co-authorship network of co-authors of S. Mattox

This figure shows the co-authorship network connecting the top 25 collaborators of S. Mattox. A scholar is included among the top collaborators of S. Mattox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Mattox. S. Mattox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Barlogie, Bart, Sundar Jagannath, S. Naucke, et al.. (1998). Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone. 1101–11071. 1 indexed citations

2.

Mehta, Jayesh, Guido Tricot, Sundar Jagannath, et al.. (1998). Salvage autologous or allogeneic transplantation for multiple myeloma refractory to or relapsing after a first-line autograft?. Bone Marrow Transplantation. 21(9). 887–892. 101 indexed citations

3.

Desikan, K.R., Bart Barlogie, Sundar Jagannath, et al.. (1998). Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.. Journal of Clinical Oncology. 16(4). 1547–1553. 135 indexed citations

4.

Barlogie, Bart, Sundar Jagannath, S. Naucke, et al.. (1998). Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone Marrow Transplantation. 21(11). 1101–1107. 39 indexed citations

5.

Mehta, Jayesh, Guido Tricot, Sundar Jagannath, et al.. (1997). High-dose chemotherapy with carboplatin, cyclophosphamide and etoposide and autologous transplantation for multiple myeloma relapsing after a previous transplant. Bone Marrow Transplantation. 20(2). 113–116. 8 indexed citations

6.

Tricot, Guido, Jeffrey R. Sawyer, Sundar Jagannath, et al.. (1997). Unique role of cytogenetics in the prognosis of patients with myeloma receiving high-dose therapy and autotransplants.. Journal of Clinical Oncology. 15(7). 2659–2666. 138 indexed citations

7.

Tricot, Guido, Bart Barlogie, Sundar Jagannath, et al.. (1995). Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood. 86(11). 4250–4256. 320 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact